Inflammation and dyslipidemia in nephropathy: an epidemiologic perspective

Abstract

The association of dyslipidemia and inflammatory markers with decreased renal function has been reported in several large epidemiologic studies. In this issue, Lin et al examine these associations among middle-aged and older type 2 diabetes, a population at high risk for chronic kidney disease. Their findings support a role for these factors in the pathogenesis of progressive renal disease.